Among the most-read coverage for the annual meeting were presentations on the potential and costs of cell and gene therapies, ...

I was diagnosed with general anxiety disorder when I was very young—I think I may have been in elementary school. Those early ...

The test does not predict which antidepressant will work best, but is being used to help suggest which ones may not work and which ones may have the greatest side effects. Pharmacogenomic testing ...

predictive testing, and pharmacogenomic testing. Carrier Testing: This type of testing helps identify individuals who carry genes for specific genetic disorders and may pass them on to their children.

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today provided an update on its engagement with UnitedHealthcare (UNH) following the Nov 1, 2024 publication ...

It also states that "the role of either pharmacogenomic testing or platelet function testing in managing therapy with thienopyridines and PPIs has not yet been established'. [45] The current ...

Mayo Clinic researchers found that a gene variant, the TPMT∗8 allele, is associated with reduced metabolism of the thiopurine class of drugs. TPMT∗8 is relatively common in individuals of African or ...

The GeneSight Psychotropic test from Myriad Genetics is the category-leading pharmacogenomic test for more than 60 medications commonly prescribed for depression, anxiety, ADHD, and other ...

Mayo Clinic researchers found that a gene variant, the TPMT∗8 allele, is associated with reduced metabolism of the thiopurine ...

While Myriad continues to engage with UNH, the company reaffirms this estimate. The GeneSight Psychotropic test from Myriad Genetics is the category-leading pharmacogenomic test for more than 60 ...